Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7001666 | 1.00 | TSHR (0.31) | TSHR | |
| SCHEMBL3806069 | 0.80 | — | — | |
| SCHEMBL14365667 | 0.74 | TSHR (0.30) | TSHR | |
| SCHEMBL16709051 | 0.74 | TSHR (0.30) | TSHR | |
| SCHEMBL2070144 | 0.74 | — | — | |
| SCHEMBL16796805 | 0.74 | — | — | |
| SCHEMBL7002111 | 0.73 | — | — | |
| SCHEMBL16796702 | 0.71 | — | — | |
| SCHEMBL3836578 | 0.71 | — | — | |
| SCHEMBL3837587 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030220503-A1 | Hydroxylation, carboxylation, cyclization, esterification, epoxidation, etherification | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-11-27 | — | — | US | disclosed |
| US-6605726-B1 | Method for producing epothilone B and derivatives, and intermediate products for this method | SCHERING AG (DE) | 2003-08-12 | — | — | US | disclosed |
| EP-1121364-B1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES THEREOF | SCHERING AG (DE) | 2003-01-08 | — | — | EP | disclosed |
| EP-1121364-A1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES, AND INTERMEDIATE PRODUCTS FOR THIS METHOD | Schering Aktiengesellschaft (DE) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000023452-A1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES, AND INTERMEDIATE PRODUCTS FOR THIS METHOD | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220503-A1 | Hydroxylation, carboxylation, cyclization, esterification, epoxidation, etherification | CYP4A11, CYP4B1, CYP4F11 | TSHR 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.